|
400 Oyster Point Blvd., Ste. 215, South San Francisco, CA |
94080 |
|
(Address of principal executive offices) |
(Zip Code) |
(Registrant's telephone number, including area code)
Email Real Estate.com, Inc.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
Effective as of October 1, 2004, the Registrant appointed David Allen Galbraith, M.D. to its Board of Directors. Dr. Galbraith currently is Area Director for Life Sciences Business Development for Ernst & Young, where he focuses on identifying promising new technologies and assisting private emerging and established public companies in the life sciences. On October 4, 2004, Dr. Galbraith was required to withdraw his acceptance of the appointment to the Board and resign as a result of a conflict with the internal policies of his employer, Ernst & Young, LLP, which prevents him from serving on the boards of for-profit corporations.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
